LicianPro

BIO stock

Bio-Rad Laboratories (BIO) earnings · next report Nov 4, 2026

BIO earnings call transcript·

Next report

Confirmed

Wed, Nov 4, 2026

After the close · Today

Quarter ended Sep 2026

EPS consensus
$2.61
Revenue consensus
—

EPS estimate trend

No estimate history stored for this quarter yet.

Date and consensus: EODHD earnings calendar and estimates, refreshed every 6 hours. “Confirmed” means the provider lists the report session, which it sets once the company announces; “Estimated” is the provider’s expected date.

Follow BIO into its report

Save it to a free watchlist (no card). Alerts when the date moves or results land are part of Pro.

Save BIO free

Earnings move

Last 1 measured report
Options price in (Nov 4)
—
No options snapshot for this report yet (taken daily in the 7 days before a report, for stocks with listed options).
Average move after earnings
±4.5%
Absolute close-to-close move, 1 report

Options-implied move: the at-the-money straddle (call + put) on the first expiry after the report, divided by the stock’s close, from EODHD end-of-day option chains. It is what the options market prices as the absolute move to that expiry, not a forecast of direction. Move: close before the news → close after it (before the open: prior close → report-day close; after the close: report-day close → next close), adjusted for splits and dividends, from EODHD end-of-day prices. Reports with an unannounced time are not averaged: both candidate moves are stored instead. Per-report moves, gaps, moves vs SPY and the sector, beat/miss asymmetry and implied vs actual are in Lician Pro below.

How to listen to the BIO earnings call

Call time and webcast from the company's SEC filing or investor relations page; times in US Eastern.

Analysts on the last call

BIO call of 2026-11-04

Technology peers with similar quant ratings

BIO is rated 2.49 of 5 among 462 rated Technology stocks (Lician quant rating, Nov 4, 2026). How the rating works

These earnings events as JSON? API free 100/day
BIO reported quarters (10-Q, GAAP diluted EPS)
QuarterRevenueEPSYoY
Q2 FY26$651.00M$13.85−0.1%
Q1 FY26$592.10M−$19.55+1.1%
Q3 FY25$653.00M−$12.70+0.5%
Q2 FY25$651.60M$11.67+2.1%

Bio-Rad Laboratories (BIO) common stock.

Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at trailing P/E 46.2.

When the next BIO 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.

The change that matters: Revenue was up 0.7% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.

Not investment advice. Full BIO research stays on the stock page; the tape stays on the quote page.

BIO earnings FAQ

When is BIO's next earnings date?

Bio-Rad Laboratories (BIO) is expected to report on Wed, Nov 4, 2026, after the close. The provider lists the session, which it sets once the company announces. Consensus EPS is $2.61.

How can I listen to the BIO earnings call?

The transcript of the Nov 4, 2026 call is at https://lician.com/earnings/bio/call/2026-11-04.

What are BIO's latest revenue and net income?

Latest cached Bio-Rad Laboratories (BIO) revenue for Dec 31, 2025 was $2.58B. Net income was $759.9M. Statements: https://lician.com/financials/bio

What is BIO's latest diluted EPS?

Latest cached Bio-Rad Laboratories (BIO) diluted EPS for Dec 31, 2025 was $27.85.

What period does the latest BIO earnings print cover?

The latest cached Bio-Rad Laboratories (BIO) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.

How did BIO revenue change from the prior cached period?

Cached Bio-Rad Laboratories (BIO) revenue was up 0.7% from $2.57B (Dec 31, 2024) to $2.58B (Dec 31, 2025). Statements: https://lician.com/financials/bio

What is BIO's P/E ratio?

Bio-Rad Laboratories (BIO) trailing P/E is 46.2 on the latest cached fundamentals snapshot.

Where are BIO earnings listed?

Cached earnings facts for Bio-Rad Laboratories (BIO) are listed at https://lician.com/earnings/bio. Statements: https://lician.com/financials/bio

Not investment advice.

Full BIO analysis